Mucinex D Tablet, Extended Release
Product Images NDC 63824-041

2 FDA label images from Reckitt Benckiser Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mucinex D (NDC 63824-041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Reckitt Benckiser Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (63824 041 Updated Label 1)

Label (63824 041 Updated Label 1)
Mucinex D Maximum Strength extended-release tablets, each containing 1200 mg Guaifenesin and 120 mg Pseudoephedrine HCl. The label highlights a bi-layer tablet with immediate-release and extended-release layers, lasting 12 hours. The package contains 24 tablets and is labeled for nasal and chest congestion relief. Labeler: Reckitt Benckiser LLC.*
FDA Label Image

Label 3 (63824 041 Updated Label 2)

Label 3 (63824 041 Updated Label 2)
Drug Facts panel of Mucinex D Maximum Strength extended-release tablets containing guaifenesin 1200 mg and pseudoephedrine HCl 120 mg. Information includes active ingredients, purposes, uses, warnings, directions, and inactive ingredients. The label advises on proper usage, precautions, and provides a consumer contact number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.